IP Library › Granted Patent US 8,600,481
Granted Patent B2
US 8,600,481 · App. 13/604,158 · Granted Dec 3, 2013

Subcutaneous cavity marking device

Inventors: D. Laksen Sirimanne (Palo Alto, CA); Douglas S. Sutton (Pacifica, CA); Natalie V. Fawzi (Belmont, CA); Gail Lebovic (Menlo Park, CA)
Assignee: Devicor Medical Products, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,600,481
App. No.
13/604,158
Granted
Dec 3, 2013
Kind
B2
Abstract

These are subcutaneous cavity marking devices and methods. More particularly, upon insertion into a body, the cavity marking device and method enable one to determine the center, orientation, and periphery of the cavity by radiographic, mammographic, echogenic, or other non-invasive imaging techniques. Also, the device contains a bioabsorbable or non-bioabsorbable marker. The device may be combined with various substances enhancing the radiopaque, mammographic, or echogenic characteristics of the marker or the body allowing it to be observed by any non-invasive imaging techniques. This is further a method of marking a subcutaneous cavity using a bioabsorbable material and a bioabsorbable or non-bioabsorbable marker in conjunction with the material. The method also may combine any of the features as described with the device.

Claims (13)

1. A subcutaneous cavity marking device percutaneously implantable in breast tissue during a biopsy procedure comprising:

at least two implantable bodies, one made from a first material and another made from a second material wherein the first and second materials are different materials and the at least two implantable bodies are adapted to be inserted into a subcutaneous cavity created by removal of tissue, wherein the at least two implantable bodies are detectable via non-invasive techniques as tissue cavity markers; and

at least one of the at least two detectable bodies has a distinguishing shape and is disposed within the other of the at least two implantable bodies wherein the other of the at least two implantable bodies is bioabsorbable.

2. The device of claim 1 wherein the at least one of the at least two detectable bodies comprises a permanent marker.

3. The device of claim 2 wherein the permanent marker comprises a material selected from the group consisting of platinum, iridium, nickel, tungsten, tantalum, gold, silver, rhodium, titanium, alloys thereof and stainless steel.

4. The device of claim 1 wherein the at least one of the at least two detectable bodies comprises a bioabsorbable material.

5. The device of claim 4 wherein the bioabsorbable material comprises a polymer having a radiopaque additive.

6. The device of claim 1 wherein the at least one of the at least two detectable bodies is radiopaque.

7. The device of claim 1 wherein one of the at least two implantable bodies is detectable via ultrasound.

8. The device of claim 1 wherein one of the at least two implantable bodies has a plurality of pores.

9. The device of claim 8 wherein the pores are configured to promote tissue growth in a preferred orientation.

10. The device of claim 1 wherein the at least one of the at least two detectable bodies includes an identifying mark.

11. The device of claim 10 wherein the identifying mark comprises one or more numbers, letters, symbols, or combinations thereof.

Continuity (4)
Continuation 09805652 · Mar 13, 2001
Continuation 09285329 · Apr 2, 1999
Continuation In Part 09220618 · Dec 24, 1998
Related Publication 20120330153A1 · Dec 27, 2012